CSS
NBRV

Cubist Systematic Strategies’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Cubist Systematic Strategies’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-134
Closed -$82K – 2661
2019
Q1 		$82K Buy
+134
New +$73.1K ﹤0.01% 2033
2018
Q3 		– Sell
-44
Closed -$38K – 2180
2018
Q2 		$38K Buy
+44
New +$50.4K ﹤0.01% 1669
2017
Q4 		– Sell
-170
Closed -$348K – 2179
2017
Q3 		$348K Buy
+170
New +$399K 0.02% 1055

Other funds holding NBRV

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Cubist Systematic Strategies's NBRV Position: Q2 2019 in Review

Cubist Systematic Strategies sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q2 2019, closing a stake of 134 shares — an estimated $82K sold.

Cubist Systematic Strategies first reported a position in NBRV in Q3 2017 and held it in 3 quarters. The position peaked at $348K in Q3 2017. 38 funds tracked by Wall St. Rank hold NBRV as of Q2 2019.

  • Cubist Systematic Strategies reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q2 2019 after selling out during the quarter.
  • Cubist Systematic Strategies sold 134 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q2 2019, an estimated $82K.
  • Cubist Systematic Strategies first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q3 2017 and held it in 3 quarters.
  • Cubist Systematic Strategies's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $348K in Q3 2017.
  • 38 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q2 2019.

Based on Cubist Systematic Strategies's 13F filing for Q2 2019, filed 14 Aug 2019.